NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 324 filers reported holding NATERA INC in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,835,734 | -9.2% | 131,881 | -0.1% | 0.04% | -4.3% |
| Q2 2023 | $6,423,801 | +2.8% | 132,014 | +17.2% | 0.05% | -2.1% |
| Q1 2023 | $6,251,108 | -10.3% | 112,592 | +64.1% | 0.05% | 0.0% |
| Q1 2021 | $6,967,000 | -25.9% | 68,613 | -27.4% | 0.05% | -31.9% |
| Q4 2020 | $9,400,000 | -15.6% | 94,456 | -38.7% | 0.07% | -28.1% |
| Q3 2020 | $11,134,000 | +19.9% | 154,131 | -17.2% | 0.10% | +17.1% |
| Q2 2020 | $9,286,000 | +95.8% | 186,245 | +17.2% | 0.08% | +60.8% |
| Q1 2020 | $4,743,000 | +28.4% | 158,857 | +44.8% | 0.05% | +75.9% |
| Q4 2019 | $3,695,000 | – | 109,672 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |